Company Description
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States.
The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.
It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013.
Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
| Country | United States |
| Founded | 2011 |
| IPO Date | May 22, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,300 |
| CEO | Andrew J. Hykes |
Contact Details
Address: 6001 Oak Canyon, Suite 100 Irvine, California 92618 United States | |
| Phone | 949-923-4747 |
| Website | inarimedical.com |
Stock Details
| Ticker Symbol | NARI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $19.00 |
| CIK Code | 0001531048 |
| CUSIP Number | 45332Y109 |
| ISIN Number | US45332Y1091 |
| Employer ID | 45-2902923 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Andrew J. Hykes | Chief Executive Officer, President and Director |
| Mitchell C. Hill | Chief Financial Officer |
| Dr. Thomas M. Tu M.D. | Chief Medical Officer |
| Paul A. Koehn | Senior Vice President of Operations |
| Kevin Strange | Senior Vice President of Finance, Accounting, Strategy and Business Development |
| John Hsu C.F.A. | Vice President of Investor Relations |
| Angela Ahmad | General Counsel and Secretary |
| Eric Khairy | Senior Vice President of Marketing |
| John R. Borrell | Senior Vice President of Sales |
| Tara Dunn | Senior Vice President and GM of LimFlow |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Mar 18, 2024 | 144 | Filing |
| Mar 15, 2024 | 144 | Filing |
| Mar 13, 2024 | ARS | Filing |
| Mar 13, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 13, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 12, 2024 | 144 | Filing |
| Feb 29, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 29, 2024 | 10-K | Annual Report |
| Feb 28, 2024 | 8-K | Current Report |